Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

AliveCor gains $10.5mm via its Series B venture round

Executive Summary

Cardiovascular device firm AliveCor Inc. has raised $10.5mm through its Series B venture round. New investor Khosla Ventures and current shareholder Burrill & Co. led and were joined by returning investors Qualcomm Ventures and Oklahoma Life Sciences Fund. The company will use the funds to launch and market its mobile electrocardiogram device once it is cleared by the FDA. Khosla Ventures will contribute one board member.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies